Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

Some studies observed a benefit of Parkinson’s disease (PD) patients after treatment with safinamide in some non-motor symptoms (NMSs). The aim of this study was to analyze the effectiveness of safinamide on NMS burden in PD. SAFINONMOTOR (an open-label study of the effectiveness of safinamide on no...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos García, Diego, Labandeira Guerra, Carmen, Yáñez Baña, Rosa, Cimas Hernando, Maria Icíar, Cabo López, Iria, Paz Gonález, Jose Manuel, Alonso Losada, Maria Gemma, González Palmás, María José, Martínez Miró, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999475/
https://www.ncbi.nlm.nih.gov/pubmed/33801565
http://dx.doi.org/10.3390/brainsci11030316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999475/
https://www.ncbi.nlm.nih.gov/pubmed/33801565
http://dx.doi.org/10.3390/brainsci11030316

Ejemplares similares